(Q26776344)

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Overall asthma control: the relationship between current control and future risk

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Efficacy and safety of budesonide/formoterol compared with salbutamol in the treatment of acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Budesonide/formoterol maintenance and reliever therapy versus conventional best practice

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Effect of salmeterol/fluticasone propionate combination on airway hyper-responsiveness in patients with well-controlled asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Beclometasone-formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Optimal asthma control, starting with high doses of inhaled budesonide.

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Effect of budesonide/formoterol maintenance and reliever therapy on asthma exacerbations.

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Comparison of two twice-daily doses of budesonide/formoterol maintenance and reliever therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness.

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Inhaled dry-powder formoterol and salmeterol in asthmatic patients: onset of action, duration of effect and potency

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Efficacy and safety profile of fluticasone/formoterol combination therapy compared to its individual components administered concurrently in asthma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Efficacy and onset of action of mometasone furoate/formoterol and fluticasone propionate/salmeterol combination treatment in subjects with persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Increasing doses of inhaled corticosteroids compared to adding long-acting inhaled beta2-agonists in achieving asthma control

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Budesonide/formoterol in a single inhaler for maintenance and relief in mild-to-moderate asthma: a randomized, double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Efficacy and safety of fluticasone furoate/vilanterol compared with fluticasone propionate/salmeterol combination in adult and adolescent patients with persistent asthma: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Fluticasone/formoterol combination therapy versus budesonide/formoterol for the treatment of asthma: a randomized, controlled, non-inferiority trial of efficacy and safety.

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Budesonide/formoterol maintenance and reliever therapy in primary care asthma management: effects on bronchial hyperresponsiveness and asthma control

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021

Potential masking of airway eosinophilic inflammation by combination therapy in asthma

1 reference

https://api.crossref.org/works/10.1016%2FJ.RMED.2015.11.002

7 January 2021